These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30347750)

  • 1. Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide.
    Ramirez-Carracedo R; Tesoro L; Hernandez I; Diez-Mata J; Filice M; Toro R; Rodriguez-Piñero M; Zamorano JL; Saura M; Zaragoza C
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis.
    Ramírez-Carracedo R; Hernández I; Moreno-Gómez-Toledano R; Díez-Mata J; Tesoro L; González-Cucharero C; Jiménez-Guirado B; Alcharani N; Botana L; Saura M; Zamorano JL; Zaragoza C
    J Hypertens; 2024 Apr; 42(4):685-693. PubMed ID: 38406874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes.
    Cuadrado I; Castejon B; Martin AM; Saura M; Reventun-Torralba P; Zamorano JL; Zaragoza C
    PLoS One; 2016; 11(9):e0162912. PubMed ID: 27649573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Contribution of Extracellular Matrix Metalloprotease Inducer-Paramagnetic Nanoparticles Against Acute Myocardial Infarction in a Pig Model of Coronary Ischemia-Reperfusion.
    Ramirez-Carracedo R; Sanmartin M; Ten A; Hernandez I; Tesoro L; Diez-Mata J; Botana L; Ovejero-Paredes K; Filice M; Alberich-Bayarri A; Martí-Bonmatí L; Largo-Aramburu C; Saura M; Zamorano JL; Zaragoza C
    Circ Cardiovasc Imaging; 2022 Jun; 15(6):e013379. PubMed ID: 35678191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction.
    Cuadrado I; Piedras MJ; Herruzo I; Turpin Mdel C; Castejón B; Reventun P; Martin A; Saura M; Zamorano JL; Zaragoza C
    Theranostics; 2016; 6(4):545-57. PubMed ID: 26941847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN.
    Lizarbe TR; Tarín C; Gómez M; Lavin B; Aracil E; Orte LM; Zaragoza C
    Am J Pathol; 2009 Oct; 175(4):1421-30. PubMed ID: 19779140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
    Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
    J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization.
    Lavin B; Gómez M; Pello OM; Castejon B; Piedras MJ; Saura M; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1739-46. PubMed ID: 24925976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
    Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
    Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma.
    Major TC; Liang L; Lu X; Rosebury W; Bocan TM
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1200-7. PubMed ID: 12117738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
    Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
    Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular matrix metalloproteinase inducer EMMPRIN is a target of nitric oxide in myocardial ischemia/reperfusion.
    Tarin C; Lavin B; Gomez M; Saura M; Diez-Juan A; Zaragoza C
    Free Radic Biol Med; 2011 Jul; 51(2):387-95. PubMed ID: 21570464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.
    Tarín C; Gomez M; Calvo E; López JA; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):27-32. PubMed ID: 18988893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
    Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
    Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
    Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
    Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting extracellular matrix metalloproteinase inducer maybe beneficial for diminishing the atherosclerotic plaque instability.
    Xie S; Nie R; Wang J
    J Postgrad Med; 2009; 55(4):284-6. PubMed ID: 20083879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional blockage of EMMPRIN ameliorates atherosclerosis in apolipoprotein E-deficient mice.
    Liu H; Yang LX; Guo RW; Zhu GF; Shi YK; Wang XM; Qi F; Guo CM; Ye JS; Yang ZH; Liang X
    Int J Cardiol; 2013 Oct; 168(4):3248-53. PubMed ID: 23642811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall.
    Schulz C; von Brühl ML; Barocke V; Cullen P; Mayer K; Okrojek R; Steinhart A; Ahmad Z; Kremmer E; Nieswandt B; Frampton J; Massberg S; Schmidt R
    J Thromb Haemost; 2011 May; 9(5):1007-19. PubMed ID: 21320284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.